Literature DB >> 10877850

Expression, characterization and structure determination of an active site mutant (Glu202-Gln) of mini-stromelysin-1.

D L Steele1, O El-Kabbani, P Dunten, L J Windsor, R U Kammlott, R L Crowther, C Michoud, J A Engler, J J Birktoft.   

Abstract

Human stromelysin-1 is a member of the matrix metalloproteinase (MMP) family of enzymes. The active site glutamic acid of the MMPs is conserved throughout the family and plays a pivotal role in the catalytic mechanism. The structural and functional consequences of a glutamate to glutamine substitution in the active site of stromelysin-1 were investigated in this study. In contrast to the wild-type enzyme, the glutamine-substituted mutant was not active in a zymogram assay where gelatin was the substrate, was not activated by organomercurials and showed no activity against a peptide substrate. The glutamine-substituted mutant did, however, bind to TIMP-1, the tissue inhibitor of metalloproteinases, after cleavage of the propeptide with trypsin. A second construct containing the glutamine substitution but lacking the propeptide was also inactive in the proteolysis assays and capable of TIMP-1 binding. X-ray structures of the wild-type and mutant proteins complexed with the propeptide-based inhibitor Ro-26-2812 were solved and in both structures the inhibitor binds in an orientation the reverse of that of the propeptide in the pro-form of the enzyme. The inhibitor makes no specific interactions with the active site glutamate and a comparison of the wild-type and mutant structures revealed no major structural changes resulting from the glutamate to glutamine substitution.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10877850     DOI: 10.1093/protein/13.6.397

Source DB:  PubMed          Journal:  Protein Eng        ISSN: 0269-2139


  9 in total

1.  Cooperation of the metalloprotease, disintegrin, and cysteine-rich domains of ADAM12 during inhibition of myogenic differentiation.

Authors:  Haiqing Yi; Joanna Gruszczynska-Biegala; Denise Wood; Zhefeng Zhao; Anna Zolkiewska
Journal:  J Biol Chem       Date:  2005-04-23       Impact factor: 5.157

2.  Internal strain drives spontaneous periodic buckling in collagen and regulates remodeling.

Authors:  Andrew Dittmore; Jonathan Silver; Susanta K Sarkar; Barry Marmer; Gregory I Goldberg; Keir C Neuman
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-11       Impact factor: 11.205

3.  A multidisciplinary approach to probing enthalpy-entropy compensation and the interfacial mobility model.

Authors:  Erin M Wilfong; Yuri Kogiso; Sivaramakrishnan Muthukrishnan; Thomas Kowatz; Yu Du; Amber Bowie; James H Naismith; Christopher M Hadad; Eric J Toone; Terry L Gustafson
Journal:  J Am Chem Soc       Date:  2011-07-07       Impact factor: 15.419

4.  NMR and bioinformatics discovery of exosites that tune metalloelastase specificity for solubilized elastin and collagen triple helices.

Authors:  Mark O Palmier; Yan G Fulcher; Rajagopalan Bhaskaran; Vinh Q Duong; Gregg B Fields; Steven R Van Doren
Journal:  J Biol Chem       Date:  2010-07-27       Impact factor: 5.157

5.  Structural and functional determinants inferred from deep mutational scans.

Authors:  Priyanka Bajaj; Kavyashree Manjunath; Raghavan Varadarajan
Journal:  Protein Sci       Date:  2022-07       Impact factor: 6.993

6.  Anomalous pH-dependence of the activity of human matrilysin (matrix metalloproteinase-7) as revealed by nitration and amination of its tyrosine residues.

Authors:  Yuko Muta; Hiroshi Oneda; Kuniyo Inouye
Journal:  Biochem J       Date:  2005-03-01       Impact factor: 3.857

7.  Solution structure of inhibitor-free human metalloelastase (MMP-12) indicates an internal conformational adjustment.

Authors:  Rajagopalan Bhaskaran; Mark O Palmier; Nusayba A Bagegni; Xiangyang Liang; Steven R Van Doren
Journal:  J Mol Biol       Date:  2007-10-16       Impact factor: 5.469

8.  A single step purification for autolytic zinc proteinases.

Authors:  Erin M Wilfong; Ursala Locklear; Eric J Toone
Journal:  Bioorg Med Chem Lett       Date:  2009-11-05       Impact factor: 2.823

9.  Mechanistic Insights into Side Effects of Troglitazone and Rosiglitazone Using a Novel Inverse Molecular Docking Protocol.

Authors:  Katarina Kores; Janez Konc; Urban Bren
Journal:  Pharmaceutics       Date:  2021-02-28       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.